Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Is Nestlé’s Turnaround Finally Gaining Momentum?

Felix Baarz by Felix Baarz
November 4, 2025
in Analysis, Consumer & Luxury, Earnings, Turnaround
0
Nestle Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

After several disappointing years, the global consumer goods behemoth is showing unexpected signs of revitalization. A surprising third-quarter performance, an analyst upgrade, and sweeping restructuring initiatives under new CEO Philipp Navratil have ignited speculation about a potential sustained recovery for the long-struggling giant.

Market Sentiment Shifts as Analyst Outlook Brightens

Berenberg, the investment bank, has significantly revised its position on Nestlé, elevating its rating from “Hold” to “Buy.” The firm also raised its price target to 92 CHF, suggesting a substantial 19 percent upside from current levels. The analysts’ rationale points to an anticipated “enhanced corporate performance across all levels of the profit and loss statement” by 2026.

This renewed confidence stems largely from the company’s October quarterly report, which delivered several positive surprises:

  • Organic growth reached 4.3%, notably surpassing the 3.7% consensus forecast.
  • Real Internal Growth (RIG) returned to positive territory, registering a 1.5% increase.
  • Pricing power was reaffirmed with price hikes of 2.8%.

The coffee and confectionery divisions were primary drivers of this recovery. However, the most significant developments are emerging from the executive suite.

New Leadership Implements Sweeping Changes

Since his unexpected promotion to CEO in September, Philipp Navratil has moved decisively. His transformation strategy is both ambitious and far-reaching, focusing on operational efficiency and cost management.

Key elements of the plan include:

Should investors sell immediately? Or is it worth buying Nestle?

  • Eliminating 16,000 positions over a two-year period.
  • Increasing cost-saving targets from 2.5 billion to 3.0 billion CHF.
  • Achieving an additional 1 billion CHF in annual cost of goods sold (COGS) efficiencies.

Navratil has stated the company is “transforming how we work,” signaling a clear intent to create a leaner, more competitive, and more profitable organization.

Underlying Challenges and Persistent Headwinds

Despite the recent optimism, Nestlé continues to face deep-seated structural issues. Berenberg itself referenced a “20-year low in performance,” highlighting several concerning financial metrics:

  • A 9% decline in earnings per share (EPS) for the current year.
  • A 25% contraction in free cash flow.
  • A leverage ratio of 3.1x, the highest level witnessed in two decades.

Regional vulnerabilities also remain a burden. The Greater China market is contending with softening consumer demand, the Gerber baby food brand is ceding market share in the United States, and the vitamin business is undergoing a strategic review.

Weighing the Investment Proposition

Nestlé shares are currently trading at 83.70 euros, a level substantially below the 52-week high of 94.88 euros. According to Berenberg, the forward P/E ratio of 17x is hovering “near 10-year lows,” potentially marking an attractive entry point for investors.

The bank’s projections for 2026 include a 4% growth in EPS and a 50-basis-point recovery in EBIT margins. Real Internal Growth is also forecast to accelerate from 0.7% to 2%.

The critical question remains whether CEO Navratil can successfully balance aggressive cost-cutting with the necessary investments to fuel long-term growth. The coming quarters will determine if this revival represents a genuine, sustainable comeback or merely a temporary flash of improvement.

Ad

Nestle Stock: Buy or Sell?! New Nestle Analysis from March 25 delivers the answer:

The latest Nestle figures speak for themselves: Urgent action needed for Nestle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nestle: Buy or sell? Read more here...

Tags: Nestle
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Next Post
Tandem Diabetes Stock

Tandem Diabetes Stock Faces Critical Earnings Test

Vulcan Energy Stock

Vulcan Energy Clears Final Regulatory Hurdle for Zero Carbon Lithium Project

Voestalpine Stock

Voestalpine Shares: Navigating Economic Headwinds and Political Shifts

Recommended

OHI stock news

Bel Fuse Director Sells 56700 Worth of Shares Amid Financial Challenges

2 years ago
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

5 months ago
Nvidia Stock

Nvidia’s Key Supplier Signals Unwavering AI Demand

2 months ago
Silber Stock

Silver’s Perfect Storm: A Market Poised for Breakout

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Trending

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

by Kennethcix
March 25, 2026
0

The semiconductor industry finds itself navigating a complex landscape where geopolitical developments intersect with tangible supply chain...

Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com